Biogen Message Board - Msg: 3232235

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen

BIIB 182.09

+0.1%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Scott who wrote (570)	1/22/1998 2:44:00 PM
From: Harold Engstrom	Read Replies (2) of 1686

Scott, while it is certainly possible that OP-1 is no longer in the clinic, I prefer to think that Jim Tobin is emphasizing those products that will emerge from trials in the shortest time frame. OP-1 will take a while by all accounts. OP-1 passed safety studies handily in its travels through the clinic with Stryker on a different indication. But, I will send an email to investor relations and see if they will confirm that there have been no safety issues and that the drug is still packed in the pipeline.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next